Literature DB >> 8973121

Solubility principles and practices for parenteral drug dosage form development.

S Sweetana1, M J Akers.   

Abstract

Solubilization of poorly water soluble or water insoluble drugs for use in intravenously administered dosage forms is a very formidable task for the parenteral formulation scientist. We have briefly reviewed pertinent literature for parenteral drug solubilization and provided tabular information to assist parenteral formulation scientists in tackling and solving their solubility problems. However, until we can better understand and predict solubility behavior in interactive solvent systems, the why's and how's for parenteral drug solubilization using acceptable (safe and regulatory compliant) approaches will largely remain an empirical effort, leaving great opportunities for scientists to get more involved in this field.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973121

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN: 1079-7440


  14 in total

Review 1.  Solubilizing excipients in oral and injectable formulations.

Authors:  Robert G Strickley
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

2.  Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation.

Authors:  Patricia V Turner; Cynthia Pekow; Mary Ann Vasbinder; Thea Brabb
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

3.  Discovery pharmaceutics--challenges and opportunities.

Authors:  Xue-Qing Chen; Melissa D Antman; Christoph Gesenberg; Olafur S Gudmundsson
Journal:  AAPS J       Date:  2006-06-02       Impact factor: 4.009

4.  Composition optimization and stability testing of a parenteral antifungal solution based on a ternary solvent system.

Authors:  Kristóf Kovács; István Antal; György Stampf; Imre Klebovich; Krisztina Ludányi
Journal:  AAPS PharmSciTech       Date:  2010-02-24       Impact factor: 3.246

5.  Aqueous and cosolvent solubility data for drug-like organic compounds.

Authors:  Erik Rytting; Kimberley A Lentz; Xue-Qing Chen; Feng Qian; Srini Vakatesh
Journal:  AAPS J       Date:  2005-04-26       Impact factor: 4.009

Review 6.  Progress in the development of alternative pharmaceutical formulations of taxanes.

Authors:  B Nuijen; M Bouma; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

7.  Stable supersaturated aqueous solutions of silatecan 7-t-butyldimethylsilyl-10-hydroxycamptothecin via chemical conversion in the presence of a chemically modified beta-cyclodextrin.

Authors:  Tian-Xiang Xiang; Bradley D Anderson
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

8.  Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.

Authors:  Xingyou Ye; Hemlata Patil; Xin Feng; Roshan V Tiwari; Jiannan Lu; Andreas Gryczke; Karl Kolter; Nigel Langley; Soumyajit Majumdar; Dipesh Neupane; Sanjay R Mishra; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2015-08-18       Impact factor: 3.246

9.  The role of difluprednate ophthalmic emulsion in clinical practice.

Authors:  Karim N Jamal; David G Callanan
Journal:  Clin Ophthalmol       Date:  2009-06-29

10.  A quantitative structure-property relationship for predicting drug solubility in PEG 400/water cosolvent systems.

Authors:  Erik Rytting; Kimberley A Lentz; Xue-Qing Chen; Feng Qian; Srini Venkatesh
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.